---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-279214"
form_type: "8-K"
ticker: "BCAB"
cik: "0001826892"
company_name: "BioAtla, Inc."
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T05:51:11.335103+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioAtla enters underwriting agreement to sell 9.745M shares at $6.67/share for $65M gross proceeds

## Summary
- Offering of 9,745,128 common shares at $6.67 each; gross proceeds $65M before discounts and expenses.
- Underwriter J.P. Morgan Securities LLC; closing expected Nov 8, 2022 subject to customary conditions.
- Offering made under Form S-3 shelf registration (File 333-262528) declared effective May 18, 2022.

## SEC filing metadata
- accession: 0001193125-22-279214
- form_type: 8-K
- ticker: BCAB
- cik: 0001826892
- company_name: BioAtla, Inc.
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826892/000119312522279214/0001193125-22-279214-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826892/000119312522279214/d380935d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-279214
- JSON: https://secwatch.observer/filing/0001193125-22-279214.json
- Plain text: https://secwatch.observer/filing/0001193125-22-279214.txt

## Key facts
- Material Agreements
  BioAtla, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC valued at $65,000,004.00 (effective 2022-11-04).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: J.P. Morgan Securities LLC
  - Value: $65,000,004.00
  - Effective: 2022-11-04
  source text: On November 4, 2022, BioAtla, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, as underwriter (the “Underwriter”), pursuant to which, the Company agreed to issue and sell to the Underwriter, and the Underwriter has agreed to purchase from the Company, an aggregate of 9,745,128 shares (the “Shares”) of its common stock, par value $0.0001 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826892/000119312522279214/0001193125-22-279214-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.